ACADIA Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $4.64 billion. The enterprise value is $3.85 billion.
| Market Cap | 4.64B |
| Enterprise Value | 3.85B |
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 169.18 million shares outstanding. The number of shares has increased by 1.70% in one year.
| Current Share Class | 169.18M |
| Shares Outstanding | 169.18M |
| Shares Change (YoY) | +1.70% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 75.43% |
| Float | 125.35M |
Valuation Ratios
The trailing PE ratio is 17.80 and the forward PE ratio is 41.44. ACAD's PEG ratio is 7.63.
| PE Ratio | 17.80 |
| Forward PE | 41.44 |
| PS Ratio | 4.39 |
| Forward PS | 3.78 |
| PB Ratio | 5.06 |
| P/TBV Ratio | 5.76 |
| P/FCF Ratio | 23.47 |
| P/OCF Ratio | 23.33 |
| PEG Ratio | 7.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.50, with an EV/FCF ratio of 19.46.
| EV / Earnings | 14.74 |
| EV / Sales | 3.68 |
| EV / EBITDA | 35.50 |
| EV / EBIT | 40.78 |
| EV / FCF | 19.46 |
Financial Position
The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.02 |
| Quick Ratio | 2.77 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.45 |
| Debt / FCF | 0.28 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 34.95% and return on invested capital (ROIC) is 7.38%.
| Return on Equity (ROE) | 34.95% |
| Return on Assets (ROA) | 5.11% |
| Return on Invested Capital (ROIC) | 7.38% |
| Return on Capital Employed (ROCE) | 9.69% |
| Revenue Per Employee | $1.60M |
| Profits Per Employee | $399,349 |
| Employee Count | 654 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 9.53 |
Taxes
In the past 12 months, ACAD has paid $12.50 million in taxes.
| Income Tax | 12.50M |
| Effective Tax Rate | 4.57% |
Stock Price Statistics
The stock price has increased by +59.81% in the last 52 weeks. The beta is 0.67, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +59.81% |
| 50-Day Moving Average | 22.64 |
| 200-Day Moving Average | 21.07 |
| Relative Strength Index (RSI) | 76.25 |
| Average Volume (20 Days) | 1,534,595 |
Short Selling Information
The latest short interest is 9.45 million, so 5.59% of the outstanding shares have been sold short.
| Short Interest | 9.45M |
| Short Previous Month | 8.51M |
| Short % of Shares Out | 5.59% |
| Short % of Float | 7.54% |
| Short Ratio (days to cover) | 5.12 |
Income Statement
In the last 12 months, ACAD had revenue of $1.05 billion and earned $261.17 million in profits. Earnings per share was $1.54.
| Revenue | 1.05B |
| Gross Profit | 617.77M |
| Operating Income | 94.41M |
| Pretax Income | 273.67M |
| Net Income | 261.17M |
| EBITDA | 108.46M |
| EBIT | 94.41M |
| Earnings Per Share (EPS) | $1.54 |
Balance Sheet
The company has $847.02 million in cash and $54.81 million in debt, giving a net cash position of $792.21 million or $4.68 per share.
| Cash & Cash Equivalents | 847.02M |
| Total Debt | 54.81M |
| Net Cash | 792.21M |
| Net Cash Per Share | $4.68 |
| Equity (Book Value) | 917.27M |
| Book Value Per Share | 5.42 |
| Working Capital | 719.84M |
Cash Flow
In the last 12 months, operating cash flow was $198.95 million and capital expenditures -$1.14 million, giving a free cash flow of $197.81 million.
| Operating Cash Flow | 198.95M |
| Capital Expenditures | -1.14M |
| Free Cash Flow | 197.81M |
| FCF Per Share | $1.17 |
Margins
Gross margin is 59.00%, with operating and profit margins of 9.02% and 24.94%.
| Gross Margin | 59.00% |
| Operating Margin | 9.02% |
| Pretax Margin | 26.14% |
| Profit Margin | 24.94% |
| EBITDA Margin | 10.36% |
| EBIT Margin | 9.02% |
| FCF Margin | 18.89% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.70% |
| Shareholder Yield | -1.70% |
| Earnings Yield | 5.63% |
| FCF Yield | 4.26% |
Analyst Forecast
The average price target for ACAD is $29.24, which is 6.56% higher than the current price. The consensus rating is "Buy".
| Price Target | $29.24 |
| Price Target Difference | 6.56% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 10.62% |
| EPS Growth Forecast (5Y) | 13.50% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 4.12 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.12 |
| Piotroski F-Score | 4 |